NSE · BSE · Real-time

Breaking Corporate Events, Analysed in Real Time

High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.

All New Order Fund Raise Expansion Earning Call Regulatory Approval Production Started Product Launched
Jaykay Enterprises Approves ₹155 Crore Rights Issue for Strategic Expansion
Fund Raise

Jaykay Enterprises Approves ₹155 Crore Rights Issue for Strategic Expansion

Jaykay Enterprises has approved a capital raise of up to ₹155 crore through a rights issue of partly paid-up equity shares. This move aims to strengthen the company's financial position as it scales its operations within the aerospace and defense manufacturing landscape.

Jaykay Enterprises Ltd (500306)
13 Jul 2026 4 min read
PDS Ltd Secures ₹2,375 Crore Annual Sourcing Contract from French Global Supermarket
New Order

PDS Ltd Secures ₹2,375 Crore Annual Sourcing Contract from French Global Supermarket

PDS Limited has signed a multi-year Sourcing as a Service (SaaS) contract with the global sourcing arm of a major French retail group. The partnership involves managing apparel sourcing operations across five key countries, representing an annual volume of approximately ₹2,375 crore.

PDS Ltd
13 Jul 2026 4 min read
Thomas Cook India Launches Zero Markup Forex Card with ₹7.5 Lakh Insurance Cover
Product Launched

Thomas Cook India Launches Zero Markup Forex Card with ₹7.5 Lakh Insurance Cover

Thomas Cook (India) Limited has relaunched its One Currency Card as the Zero Markup Forex Card to target the growing segment of digitally savvy international travelers. The card eliminates traditional forex markups and cross-currency conversion fees while allowing users to lock in exchange rates before travel.

Thomas Cook (India) Ltd
13 Jul 2026 4 min read
RPG Life Sciences Launches Naprosyn ES; First-of-its-Kind Combo in India
Product Launched

RPG Life Sciences Launches Naprosyn ES; First-of-its-Kind Combo in India

RPG Life Sciences has partnered with Archerchem Healthcare to launch Naprosyn ES, a fixed-dose combination of Naproxen and Esomeprazole, in the Indian market. This product marks the first time this specific anti-inflammatory and gastro-protective combination is available in India, targeting patients requiring long-term pain management.

RPG Life Sciences Limited
13 Jul 2026 4 min read
BCL Industries Commissions 150 KLPD Ethanol Expansion in Bathinda
Production Started

BCL Industries Commissions 150 KLPD Ethanol Expansion in Bathinda

BCL Industries has successfully commissioned a 150 KLPD ethanol-dedicated brownfield expansion at its Bathinda facility. This operational milestone increases the plant’s total distillery capacity to 550 KLPD, significantly strengthening its footprint in India’s grain-based ethanol market.

BCL Industries Ltd-$ (524332)
13 Jul 2026 4 min read
Stellant Securities Promoter Mangala Subhash Rathod Acquires Shares Worth ₹5.1 Crore
Fund Raise

Stellant Securities Promoter Mangala Subhash Rathod Acquires Shares Worth ₹5.1 Crore

Mangala Subhash Rathod, a promoter of Stellant Securities (India) Ltd, has converted 1,50,000 warrants into equity shares at a price of ₹340 per unit. This ₹5.1 crore transaction raises the promoter group's voting shareholding to 45.25%, reflecting a continued consolidation of ownership within the firm.

Stellant Securities (India) Ltd
11 Jul 2026 3 min read
Hero MotoCorp Launches VIDA EVOOTER VX2 Plus 4.4 kWh With 187 KM Range
Product Launched

Hero MotoCorp Launches VIDA EVOOTER VX2 Plus 4.4 kWh With 187 KM Range

Hero MotoCorp has expanded its electric vehicle portfolio with the introduction of the VIDA EVOOTER VX2 Plus 4.4 kWh variant. This long-range model aims to address consumer range anxiety while reinforcing the company's vision through competitive pricing and enhanced charging infrastructure.

Hero MotoCorp Ltd (500182)
10 Jul 2026 4 min read
Bayer AG Increases Direct Stake in Bayer CropScience to 20.34% via Block Deal
Regulatory Approval

Bayer AG Increases Direct Stake in Bayer CropScience to 20.34% via Block Deal

Bayer AG, a primary promoter of Bayer CropScience Limited, has increased its direct equity stake in the company to 20.34%. This was achieved through the acquisition of 53,54,030 shares from another group promoter via an inter-se block deal mechanism.

Bayer CropScience Ltd
10 Jul 2026 4 min read
Wheels India Board Approves Strategic ₹400 Crore Fund Raise via Equity and Debt
Fund Raise

Wheels India Board Approves Strategic ₹400 Crore Fund Raise via Equity and Debt

Wheels India Limited has announced a major capital infusion plan of up to ₹400 crore through various financial instruments. The board has authorized the issuance of equity shares and convertible securities to strengthen the company's financial structure and support its long-term growth objectives.

Wheels India Limited
10 Jul 2026 4 min read